AbCellera Biologics Inc. (ABCL) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for AbCellera Biologics Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -6.98x | -5.30x | -11.28x | 18.22x | 25.70x | 90.63x |
| P/B Ratio | 0.90x | 0.82x | 1.43x | 2.34x | 3.84x | 12.98x |
| P/S Ratio | 13.60x | 29.91x | 43.42x | 5.95x | 10.51x | 46.22x |
| Profitability | ||||||
| Gross Margin | 61.6% | 100.0% | 100.0% | 86.3% | 87.9% | 88.4% |
| Operating Margin | -289.0% | -1091.7% | -623.8% | 44.6% | 54.5% | 66.9% |
| Net Margin | -194.9% | -564.8% | -385.0% | 32.7% | 40.9% | 51.0% |
| EBITDA Margin | -250.6% | -708.0% | -505.3% | 53.6% | 63.7% | 72.7% |
| Liquidity | ||||||
| Current Ratio | 11.32x | 9.81x | 7.33x | 8.67x | 7.70x | 7.86x |
| Quick Ratio | 11.23x | 9.81x | 7.32x | 8.65x | 7.69x | 7.85x |
| Leverage | ||||||
| Debt/Equity | 0.13x | 0.06x | 0.07x | 0.07x | 0.04x | 0.01x |
YoY = year-over-year change. Source: FMP..